Biology subjects

Garenne, D.

Publications and source records attributed to Garenne, D..

5 recordsLinked to original sources

bioRxiv2026

Engineering erythrocytes into synthetic cells using cell-free gene expression

Erythrocytes, commonly known as red blood cells (RBCs), constitute the most abundant cell type in vertebrate mammals. Due to their unique biological and physical attributes, RBCs have been the focus of extensive research in biomedical engineering. Methods have been developed to transform RBCs into adaptable carriers for molecular payloads, thereby extending their functional capabilities beyond what they naturally transport and accomplish. Concurrently with RBCs applied science, cell-free gene expression (CFE) has advanced into a tractable technology that can be integrated with a broad range of materials. In this work, we harness the advantages of CFE to engineer RBCs into hybrid synthetic cells. We encapsulate CFE reactions within RBC ghosts to execute elementary gene circuits, including biosensors, and to synthesize phages from their genomes. Furthermore, we engineer and functionalize the outer membrane of mature RBCs to attach diverse payloads, such as a SARS-CoV-2 antigen recognized by a specific antibody. CFE interfaces remarkably well with RBCs, enabling their rapid, low-cost transformation into red blood synthetic cells (RBSCs) with potential biomedical and biotechnological applications.

bioengineering↗

bioRxiv2026

Programming Metabolic Dependency in Synthetic Cells Under Resource Scarcity

Engineering synthetic cells where metabolism directly controls gene expression is one of the greatest challenges in synthetic biology. This coupling between metabolic activity and protein synthesis is also thought to have been a vital step in the evolution of the earliest cellular life. This fundamental process is essential for developing minimal, self-sustaining cells, both engineered for biotechnology applications and as models explaining the origins of life. Here, we present a programmable cell-free platform that links metabolic activity to translation under defined resource limitations. Using an engineered amino-acid-dependent cell-free translation system, we introduced a tunable metabolic bottleneck (depleting tyrosine). This enabled imposing a controlled metabolic constraint on protein synthesis. To alleviate this constraint, we then incorporated phenylalanine hydroxylase (PAH) as a minimal module for tyrosine synthesis. The PAH-driven tyrosine synthesis established a system in which protein expression is directly controlled by amino acid biosynthesis. This relationship was recapitulated in liposome compartments, resulting in three distinct synthetic cell populations. The metabolically active population had significantly higher fitness in protein production. Overall, this work establishes an experimentally tractable platform to investigate how primitive cells may have evolved internal metabolic capabilities, and it represents a foundational step toward constructing more autonomous and self-regulating synthetic cells.

biochemistry↗

bioRxiv2025

A synthetic cell phage cycle

Viral infection of living cells, exemplified by bacteriophage interaction with bacteria, is fundamental to biology and universal across living systems. Here, we establish an all-cell-free viral cycle where T7 phages infect synthetic cells, equipped with lipopolysaccharides on the outer leaflet of the lipid membrane while encapsulating a cell-free gene expression system. We track each cycle step to demonstrate T7 phage-specific adsorption onto the liposomes, genome ejection, replication, expression, and assembly of new infectious virions within the synthetic cells. We quantify key characteristics of the cycle, including the multiplicity of infection, replication efficiency, liposome size constraints, and phage rebinding dynamics. This work establishes a versatile, fully defined in vitro platform for reconstructing and investigating viral infections from individual molecular components.

synthetic biology↗

bioRxiv2024

Carbon-conserving Bioproduction of Malate in an E. coli-based Cell-Free System

Formate, a biologically accessible form of CO2, has attracted interest as a renewable feedstock for bioproduction. However, approaches are needed to investigate efficient routes for biological formate assimilation due to its toxicity and limited utilization by microorganisms. Cell-free systems hold promise due to their potential for efficient use of carbon and energy sources and compatibility with diverse feedstocks. However, bioproduction using purified cell-free systems is limited by costly enzyme purification, whereas lysate-based systems must overcome loss of flux to background reactions in the cell extract. Here, we engineer an E. coli-based system for an eight-enzyme pathway from DNA and incorporate strategies to regenerate cofactors and minimize loss of flux through background reactions. We produce the industrial di-acid malate from glycine, bicarbonate, and formate by engineering the carbon-conserving reductive TCA and formate assimilation pathways. We show that in situ regeneration of NADH drives metabolic flux towards malate, improving titer by 15-fold. Background reactions can also be reduced 6-fold by diluting the lysate following expression and introducing chemical inhibitors of competing reactions. Together, these results establish a carbon-conserving, lysate-based cell-free platform for malate production, producing 64 M malate after 8 hours. This system conserves 43% of carbon otherwise lost as CO2 and incorporates 0.13 mol CO2 equivalents/mol glycine fed. Finally, techno-economic analysis of cell-free malate production from formate revealed that the high cost of lysate is a key challenge to the economic feasibility of the process, even assuming efficient cofactor recycling. This work demonstrates the capabilities of cell-free expression systems for both the prototyping of carbon-conserving pathways and the sustainable bioproduction of platform chemicals. HighlightsO_LISuccessfully engineered the carbon-conserving reductive TCA and formate assimilation pathways in a lysate-based cell-free system for production of the C4 industrial di-acid malate from C1 and C2 feedstocks. C_LIO_LIAchieved a 6-fold reduction in competition from the endogenous cell-free metabolism by blocking TCA activity using small-molecule inhibitors and lysate dilution. C_LIO_LIIncreased accumulation of malate by 15-fold in a single-step reaction using cell-free expression of an enzymatic cofactor regeneration system. C_LIO_LITechno-economic analysis identified routes for economically feasible production of malate from renewable feedstocks in a cell-free system by improving conversion efficiency and reducing lysate cost. C_LI Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=161 SRC="FIGDIR/small/623433v1_ufig1.gif" ALT="Figure 1"> View larger version (29K): org.highwire.dtl.DTLVardef@3c89adorg.highwire.dtl.DTLVardef@72d9b3org.highwire.dtl.DTLVardef@327e2eorg.highwire.dtl.DTLVardef@fa0964_HPS_FORMAT_FIGEXP M_FIG C_FIG

synthetic biology↗

bioRxiv2018

Multiplex transcriptional characterizations across diverse and hybrid bacterial cell-free expression systems

Cell-free expression systems enable rapid prototyping of genetic programs in vitro. However, current throughput of cell-free measurements is often limited by the use of single-channel reporter assays. Here, we describe DNA Regulatory element Analysis by cell-Free Transcription and Sequencing (DRAFTS), a rapid and robust in vitro approach for multiplexed measurement of transcriptional activities from thousands of regulatory sequences in a single reaction. We employed this method in active cell lysates developed from ten diverse bacterial species. Interspecies analysis of transcriptional profiles from >1,000 diverse regulatory sequences revealed functional differences in gene expression that could be predictively modeled. Finally, we constructed and examined the transcriptional capacities of dual-species \"hybrid\" cell lysates that can simultaneously harness gene expression properties of multiple organisms. We expect that this cell-free multiplex transcriptional measurement approach will improve genetic circuit prototyping in new bacterial chassis for synthetic biology.

synthetic biology↗